Safety of Regenerative Medicine Injections
Regenerative medicine specialists Kirk Scofield, M.D., and Andrew Clary, D.O., explain Summit Orthopedics’ dedication to safety and expertise in regenerative injection therapies, as well as how traditional injections compare to regenerative approaches.
Kirk Scofield, M.D.: There are other forms of regenerative medicine and regenerative treatments for orthopedic conditions that have been studied. But currently, we’re offering, really, the primary options that meet FDA guidelines for regenerative conditions.
Andrew Clary, D.O.: We’ve got a really well-educated team here. We have specialists who have done this, who have read about this, who’ve studied this, who know as much about this as any specialists, frankly, in the region or beyond. With the experience that we have here, the procedure is as comfortable as can be. Harvesting or taking of the cells from that hip area is done, again, with a lot of numbing medication specifically targeted with image guidance to make sure we’re going in the right spots.
Kirk Scofield, M.D.: Since the 1940s or 50s, we’ve been doing cortisone injections into arthritic joints, and doing that actually does relieve pain significantly, but usually, it’s pretty short-lived. And we know that if we continue to do cortisone over and over in a place, there are some potential side effects, both locally to the joint or tissue where we’re injecting it, that could actually potentially accelerate the new generation of that joint or tissue. And also systemically, there are some potential bad side effects. So in comparison, doing a PRP injection or a bone marrow injection into a joint, is going to relieve pain generally, but also may actually be healthy for the joint rather than detrimental to the joint over time.
A physical therapist explains what you can expect during your first physical therapy appointment.
Learn how physical therapy is successfully used to treat and relieve foot pain.
Learn about what you can do if you suspect you have an unhealed fracture.